Anti-Spike-RBD mAb

Anti-Spike-RBD mAb

Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach for SARS-CoV-2 treatment[1].

 

 

 

[accordions]
[accordion title= “Chemical Properties“]

Molecular Weight N/A

[/accordion]

 

 

 

[accordions]
[accordion title= “References and Literature“]

1. Chunyan Wang, et al. A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection. Nat Commun. 2020 May 4;11(1):2251.

[/accordion]